Free Trial

2,087 Shares in AMETEK, Inc. (NYSE:AME) Bought by Sagespring Wealth Partners LLC

AMETEK logo with Computer and Technology background

Sagespring Wealth Partners LLC bought a new stake in shares of AMETEK, Inc. (NYSE:AME - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 2,087 shares of the technology company's stock, valued at approximately $376,000.

A number of other institutional investors also recently bought and sold shares of AME. Vanguard Group Inc. boosted its position in shares of AMETEK by 1.1% during the fourth quarter. Vanguard Group Inc. now owns 26,147,772 shares of the technology company's stock valued at $4,713,397,000 after purchasing an additional 282,208 shares in the last quarter. FMR LLC boosted its holdings in shares of AMETEK by 1.1% during the 4th quarter. FMR LLC now owns 8,956,329 shares of the technology company's stock valued at $1,614,468,000 after buying an additional 98,546 shares in the last quarter. JPMorgan Chase & Co. grew its position in shares of AMETEK by 3.7% in the 3rd quarter. JPMorgan Chase & Co. now owns 6,985,350 shares of the technology company's stock worth $1,199,454,000 after buying an additional 250,538 shares during the period. Geode Capital Management LLC increased its stake in shares of AMETEK by 2.3% in the 4th quarter. Geode Capital Management LLC now owns 5,526,369 shares of the technology company's stock worth $993,546,000 after acquiring an additional 124,713 shares in the last quarter. Finally, Bank of New York Mellon Corp lifted its position in AMETEK by 2.3% during the 4th quarter. Bank of New York Mellon Corp now owns 4,415,508 shares of the technology company's stock valued at $795,939,000 after acquiring an additional 99,505 shares during the period. 87.43% of the stock is owned by institutional investors.

AMETEK Trading Down 0.5 %

AME traded down $0.86 on Friday, hitting $157.66. The company had a trading volume of 1,698,788 shares, compared to its average volume of 1,284,129. The business's fifty day simple moving average is $174.27 and its 200 day simple moving average is $179.62. The company has a quick ratio of 0.75, a current ratio of 1.24 and a debt-to-equity ratio of 0.15. AMETEK, Inc. has a 12-month low of $145.02 and a 12-month high of $198.33. The company has a market cap of $36.38 billion, a PE ratio of 26.59, a PEG ratio of 2.73 and a beta of 1.14.

AMETEK (NYSE:AME - Get Free Report) last announced its quarterly earnings data on Tuesday, February 4th. The technology company reported $1.87 EPS for the quarter, beating the consensus estimate of $1.85 by $0.02. The company had revenue of $1.76 billion for the quarter, compared to the consensus estimate of $1.82 billion. AMETEK had a return on equity of 16.94% and a net margin of 19.83%. AMETEK's quarterly revenue was up 1.8% on a year-over-year basis. During the same quarter in the prior year, the company posted $1.68 EPS. Equities research analysts expect that AMETEK, Inc. will post 7.15 EPS for the current year.

AMETEK Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Monday, March 31st. Stockholders of record on Friday, March 14th were paid a dividend of $0.31 per share. The ex-dividend date was Friday, March 14th. This is an increase from AMETEK's previous quarterly dividend of $0.28. This represents a $1.24 dividend on an annualized basis and a dividend yield of 0.79%. AMETEK's dividend payout ratio (DPR) is currently 20.91%.

AMETEK announced that its Board of Directors has approved a share repurchase program on Friday, February 7th that permits the company to buyback $1.25 billion in outstanding shares. This buyback authorization permits the technology company to reacquire up to 2.9% of its shares through open market purchases. Shares buyback programs are generally a sign that the company's board of directors believes its shares are undervalued.

Analysts Set New Price Targets

A number of research analysts have issued reports on the company. Morgan Stanley started coverage on AMETEK in a research note on Monday. They set an "equal weight" rating and a $170.00 price objective for the company. BNP Paribas upgraded AMETEK from a "neutral" rating to an "outperform" rating and set a $210.00 price target on the stock in a research note on Thursday, January 16th. Robert W. Baird reduced their target price on shares of AMETEK from $200.00 to $197.00 and set a "neutral" rating for the company in a report on Wednesday, February 5th. StockNews.com cut AMETEK from a "buy" rating to a "hold" rating in a research report on Friday, April 11th. Finally, Truist Financial decreased their price objective on shares of AMETEK from $216.00 to $196.00 and set a "buy" rating on the stock in a research report on Tuesday, April 8th. One research analyst has rated the stock with a sell rating, four have given a hold rating, seven have given a buy rating and one has given a strong buy rating to the company's stock. According to MarketBeat.com, AMETEK presently has a consensus rating of "Moderate Buy" and a consensus price target of $198.60.

Get Our Latest Stock Report on AME

Insider Buying and Selling at AMETEK

In other AMETEK news, Director Steven W. Kohlhagen sold 1,320 shares of the company's stock in a transaction on Monday, March 3rd. The shares were sold at an average price of $189.41, for a total value of $250,021.20. Following the sale, the director now directly owns 22,029 shares of the company's stock, valued at approximately $4,172,512.89. This represents a 5.65 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Thomas A. Amato sold 710 shares of the business's stock in a transaction dated Thursday, March 27th. The shares were sold at an average price of $176.64, for a total value of $125,414.40. Following the completion of the transaction, the director now directly owns 10,560 shares of the company's stock, valued at approximately $1,865,318.40. This trade represents a 6.30 % decrease in their position. The disclosure for this sale can be found here. Insiders own 0.57% of the company's stock.

About AMETEK

(Free Report)

AMETEK, Inc manufactures and sells electronic instruments and electromechanical devices in the North America, Europe, Asia, and South America, and internationally. The company's EIG segment offers advanced instruments for the process, aerospace, power, and industrial markets; process and analytical instruments for the oil and gas, petrochemical, pharmaceutical, semiconductor, automation, and food and beverage industries; instruments to the laboratory equipment, ultra-precision manufacturing, medical, and test and measurement markets; power quality monitoring and c devices, uninterruptible power supplies, programmable power and electromagnetic compatibility test equipment, and sensors for gas turbines and dashboard instruments; heavy trucks, instrumentation, and controls for the food and beverage industries; and aircraft and engine sensors, power supplies, embedded computing, monitoring, fuel and fluid measurement, and data acquisition systems for aerospace and defense industry.

Further Reading

Institutional Ownership by Quarter for AMETEK (NYSE:AME)

Should You Invest $1,000 in AMETEK Right Now?

Before you consider AMETEK, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and AMETEK wasn't on the list.

While AMETEK currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Buy the Fear: 3 Down Stocks That Could 10x Your Profits
Congress Bought THESE Stocks as Tariffs Tanked the Market
5 Stocks to BUY Now as Tariff Uncertainty Fades

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines